Evidence map›Paper›PMID 38499041›Full record

ArticleDeutsche medizinische Wochenschrift (1946)2024

[Infectious Diseases - a new specialty for postgraduate training in Germany].

Maria J G T Vehreschild, Gerd Fätkenheuer, Leif Erik Sander, Christoph Lübbert, Siegbert Rieg, Georg Ertl, Bernd Salzberger

Abstract readEnglish Abstract
In one paragraph

Article in Deutsche medizinische Wochenschrift (1946), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria J G T VehreschildGoethe Universität Frankfurt, Universitätsklinikum Frankfurt, Zentrum für Innere Medizin, Infektiologie, Frankfurt am Main.
Gerd FätkenheuerKlinik I für Innere Medizin, Schwerpunkt Infektiologie, Universitätsklinikum Köln.
Leif Erik SanderKlinik für Infektiologie und Intensivmedizin, Charité - Universitätsmedizin, Berlin.
Christoph LübbertBereich Infektiologie und Tropenmedizin, Department für Innere Medizin, Neurologie und Dermatologie, Universitätsmedizin Leipzig.
Siegbert RiegAbteilung Infektiologie, Klinik für Innere Medizin II, Universitätsklinikum Freiburg.
Georg ErtlDeutsche Gesellschaft für Innere Medizin (DGIM), Wiesbaden.
Bernd SalzbergerAbteilung Krankenhaushygiene und Infektiologie, Universitätsklinikum Regensburg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicine in Germany is currently facing major structural and economic challenges. Infectious Diseases, with the recent introduction of a new specialty in "Internal Medicine and Infectious Diseases" and with the existing additional training for almost all specializations, will make an important contribution to overcoming these challenges. Expertise in infectious diseases has to be very broad and requires high interdisciplinarity, which makes infectious diseases an attractive and demanding specialty. The complex fundamentals of infectious diseases must now be quickly conveyed to as many physicians as possible in a short period of time, as part of their specialization or as additional training. Until this is achieved, transitional solutions will be necessary for some time. The adaptation of the current billing and reimbursement system for infectious diseases services and improved intersectoral cooperation are of the utmost importance for the further development of the specialty.

Indexed as

Communicable DiseasesPhysiciansEducation, Medical, GraduateGermanyHumansInternal MedicineSpecialization

Identifiers

PMID38499041
PMCPMC11018382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.